| CAS No. | 857890-39-2 |
|---|---|
| MDL No. | MFCD18633219 |
| MF | C22H23ClN4O7S |
| MW | 523.00 |
| InChI Key | HWLFIUUAYLEFCT-UHFFFAOYSA-N |
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| - | - | On Request | On Request | |
| Custom synthesis and bulk supply options are available upon request. | ||||
Lenvatinib mesylate is the methanesulfonate salt of lenvatinib, formed by reaction with one molar equivalent of methanesulfonic acid. It is a multi-kinase inhibitor and orphan drug, used in the treatment of thyroid cancers resistant to radioiodine. It functions as an EC 2.7.10.1 inhibitor, fibroblast growth factor receptor antagonist, vascular endothelial growth factor receptor antagonist, and antineoplastic agent. It contains lenvatinib(1+).
| CAS No. | 857890-39-2 |
|---|---|
| Product Name | Lenvatinib Mesylate |
